INVITRO ACTIVITY OF CEFIXIME AND 6 OTHER AGENTS AGAINST NOSOCOMIAL PATHOGENS OF THE ENTEROBACTERIACEAE FAMILY

被引：1

作者：

MULLIGAN, ME

KWOK, YY

机构：

[1] W LOS ANGELES VET ADM MED CTR,RES SERV,LOS ANGELES,CA 90073

[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024

来源：

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 1987年 / 8卷 / 06期

关键词：

D O I：

10.1017/S019594170006611X

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：241 / 244

页数：4

共 11 条

[1] THE PHARMACOKINETIC AND BACTERICIDAL CHARACTERISTICS OF ORAL CEFIXIME [J].

BRITTAIN, DC ;

SCULLY, BE ;

HIROSE, T ;

NEU, HC .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :590-594

[2] INVITRO EVALUATION OF CEFIXIME (FK027, FR17027, CL284635) - SPECTRUM AGAINST RECENT CLINICAL ISOLATES, COMPARATIVE ANTIMICROBIAL ACTIVITY, BETA-LACTAMASE STABILITY, AND PRELIMINARY SUSCEPTIBILITY TESTING CRITERIA [J].

FUCHS, PC ;

JONES, RN ;

BARRY, AL ;

THORNSBERRY, C ;

AYERS, LW ;

GAVAN, TL ;

GERLACH, EH .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 5 (02) :151-162

[3]

KAMIDONO S, 1985, 14TH INT C CHEM KYOT

[4] INVITRO AND INVIVO ANTIBACTERIAL PROPERTIES OF FK-027, A NEW ORALLY ACTIVE CEPHEM ANTIBIOTIC [J].

KAMIMURA, T ;

KOJO, H ;

MATSUMOTO, Y ;

MINE, Y ;

GOTO, S ;

KUWAHARA, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) :98-104

[5]

KISHI H, 1985, 14TH INT C CHEM KYOT

[6]

KONISHI K, 1985, 14TH INT C CHEM KYOT

[7] COMPARATIVE INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF FR-17027, A NEW ORALLY ACTIVE CEPHALOSPORIN [J].

NEU, HC ;

CHIN, NX ;

LABTHAVIKUL, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :174-180

[8]

OHI Y, 1985, 14TH INT C CHEM KYOT

[9]

STEERS EDWARD, 1959, ANTIBIOT AND CHEMOTHER, V9, P307

[10]

SUZUKI K, 1985, 14TH INT C CHEM KYOT

← 1 2 →